| Risk group category | Recommendation |
| Solid organ transplant | - Cytology is recommended if younger than 30 years.
- Co-testing is preferred, but cytology is acceptable if 30 years or older.
- If using cytology alone, perform annual cervical cytology. If results of 3 consecutive cytology results are normal, perform cytology every 3 years.
- If using co-testing, perform baseline co-test with cytology and HPV. If result of cytology is normal and HPV is negative, co-testing can be performed every 3 years.
- Continue screening throughout lifetime (older than 65 years). Discontinue screening based on shared discussion regarding quality and duration of life rather than age.
- Screen patients on dialysis and posttransplant similarly.
|
| Allogeneic hematopoietic stem cell transplant | - Cytology is recommended if younger than 30 years.
- Co-testing is preferred, but cytology is acceptable if 30 years or older.
- If using cytology alone, perform annual cervical cytology. If results of 3 consecutive cytology results are normal, perform cytology every 3 years.
- If using co-testing, perform baseline co-test with cytology and HPV. If result of cytology is normal and HPV is negative, co-testing can be performed every 3 years.
- Continue screening throughout lifetime (older than 65 years). Discontinue screening based on shared discussion regarding quality and duration of life rather than age.
- For HSCT patients who develop a new diagnosis of genital GVHD or chronic GVHD, resume annual cervical cytology until 3 consecutive normal results at which time perform cytology every 3 years, or perform an initial baseline co-test and, if cytology is normal and HPV is negative, perform co-testing every 3 years.
|
| Inflammatory bowel disease on immunosuppressant treatments | - Cytology is recommended if younger than 30 years.
- Co-testing is preferred, but cytology is acceptable if 30 years or older.
- If using cytology alone, perform annual cervical cytology. If results of 3 consecutive cytology results are normal, perform cytology every 3 years.
- If using co-testing, perform baseline co-test with cytology and HPV. If result of cytology is normal and HPV is negative, co-testing can be performed every 3 years.
- Continue screening throughout lifetime (older than 65 years). Discontinue screening based on shared discussion regarding quality and duration of life rather than age.
|
| Inflammatory bowel disease not on immunosuppressant treatments | - Follow general population screening guidelines.
|
| Systemic lupus erythematosus and rheumatoid arthritis on immunosuppressant treatments | - Cytology is recommended if younger than 30 years.
- Co-testing is preferred, but cytology is acceptable if 30 years or older.
- If using cytology alone, perform annual cervical cytology. If results of 3 consecutive cytology results are normal, perform cytology every 3 years.
- If using co-testing, perform baseline co-test with cytology and HPV. If result of cytology is normal and HPV is negative, co-testing can be performed every 3 years.
- Continue screening throughout lifetime (older than 65 years). Discontinue screening based on shared discussion regarding quality and duration of life rather than age.
|
| Rheumatoid arthritis not on immunosuppressive treatments | - Follow general population screening guidelines.
|
| Type 1 diabetes mellitus | - Follow general population screening guidelines.
|
